KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Blood

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2005-08-3408PMID 16291592
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

  2005cited by this paper
• Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22)

  2005cited by this paper
• Imatinib mesylate for refractory acute myeloblastic leukemia harboring inv(16) and a C-KIT exon 8 mutation

  2005cited by this paper
• Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia

  2005cited by this paper
• Excellent Outcome of Risk Stratified Treatment for Childhood Acute Myeloid Leukemia-AML99 Trial. For the Japanese Childhood AML Cooperative Study Group.

  2005cited by this paper
• KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication.

  2004cited by this paper
• Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.

  2004cited by this paper
• FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance.

  2003cited by this paper
• AML with t(8;21) and trisomy 4: possible involvement of c-kit?

  2003cited by this paper
• Incidence and prognosis of c‐KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias

  2003cited by this paper
• Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia.

  2003influential reference
• FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy.

  2003cited by this paper
• A white blood cell index as the main prognostic factor in t ( 8 ; 21 ) acute myeloid leukemia ( AML ) : a survey of 161 cases from the French AML Intergroup

  2002cited by this paper
• In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia.

  2002cited by this paper
• Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution's experience

  2002cited by this paper
• A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup.

  2002cited by this paper
• Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.

  2002cited by this paper
• Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

  2002cited by this paper
• AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations

  2001cited by this paper
• Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

  2001cited by this paper
• C-kit mutations in core binding factor leukemias.

  2000cited by this paper
• c‐kit proto‐oncogene exon 8 in‐frame deletion plus insertion mutations in acute myeloid leukaemia

  1999cited by this paper
• Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children

  1999cited by this paper
• Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines

  1997cited by this paper
• Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).

  1997cited by this paper

• Prognostic significance of cytogenetic and molecular features in pediatric acute myeloid leukemia: a meta-analysis

  2025cites this paper
• Prospective Evaluation of KIT Mutations and Long-Term Outcomes in Pediatric Core Binding Factor Acute Myeloid Leukemia: A Single Institutional Study in China.

  2025cites this paper
• High temporal resolution prediction of mortality risk for single AML patient via deep learning

  2024cites this paper
• Prognostic Factors of Pediatric Acute Myeloid Leukemia Patients with t(8;21) (q22;q22): A Single-Center Retrospective Study

  2024cites this paper
• Comprehensive molecular understanding of pediatric acute myeloid leukemia

  2023cites this paper
• KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1

  2023cites this paper
• Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia

  2022cites this paper
• Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspective

  2022cites this paper
• Droplet digital polymerase chain reaction assay for the detection of the minor clone of KIT D816V in paediatric acute myeloid leukaemia especially showing RUNX1‐RUNX1T1 transcripts

  2021cites this paper
• Bilateral parotid gland enlargement as a presenting manifestation of relapsed pediatric acute myeloid leukemia

  2021cites this paper
• Additional Cytogenetic Aberrations Indicative of Poor Prognosis in AML with RUNX1/RUNX1T1 Rearrangement: Karyotype a Chromosomal Blueprint

  2021cites this paper
• Treatment Failure in Acute Myeloid Leukemia: Focus on the Role of Extracellular Vesicles.

  2021cites this paper
• Molecular Genetics of Pediatric Acute Myeloid Leukemia.

  2021cites this paper
• Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia

  2021cites this paper
• c-Kit - The Novel Receptor: Physiological Roles, Downstream Signaling and Implications in Cancer

  2021cites this paper
• Treatment of acute myeloid leukemia in children: A practical perspective

  2021cites this paper
• Population Pharmacokinetics and Safety of Dasatinib in Chinese Children with Core-Binding Factor Acute Myeloid Leukemia

  2021cites this paper
• Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroup

  2020cites this paper
• The genomics of acute myeloid leukemia in children

  2020cites this paper
• Influence of KIT mutations on prognosis of pediatric patients with core-binding factor acute myeloid leukemia: a systematic review and meta-analysis

  2020cites this paper
• The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05R study

  2020cites this paper
• 二代测序检测克隆性基因突变对RUNX1-RUNX1T1阳性急性髓系白血病的预后价值

  2020cites this paper
• Acute Myeloid Leukemia with t(8;21)(q22;q22) and Trisomy 4: A Rare Occurrence in a Female Child

  2019cites this paper
• C-kit mutacija u akutnoj mijeloičnoj leukemiji s preuredbom gena grupe CBF

  2019cites this paper
• Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML‐05 study

  2019cites this paper
• Hematological malignancies and molecular targeting therapy.

  2019cites this paper
• Prognostic Role of Postinduction Minimal Residual Disease and Myeloid Sarcoma Type Extramedullary Involvement in Pediatric RUNX1-RUNX1T1 (+) Acute Myeloid Leukemia

  2019cites this paper
• Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia

  2019cites this paper
• Assessing Measurable Residual Disease in Acute Myeloid Leukemia

  2019cites this paper
• Negative CD19 expression is associated with inferior relapse‐free survival in children with RUNX1‐RUNX1T1–positive acute myeloid leukaemia: results from the Japanese Paediatric Leukaemia/Lymphoma Study Group AML‐05 study

  2019cites this paper
• 儿童核心结合因子相关性急性髓系白血病疗效及预后因素分析

  2019cites this paper
• KIT mutations correlate with adverse survival in children with core-binding factor acute myeloid leukemia

  2018influential citation
• Core‐binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I‐CBFit)

  2018cites this paper
• Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Part I Cytogenetic Abnormalities

  2018cites this paper
• Precision Molecular Pathology of Myeloid Neoplasms

  2018cites this paper
• Detection of KIT mutations in core binding factor acute myeloid leukemia

  2018cites this paper
• Clinical challenges in de novo pediatric acute myeloid leukemia

  2018cites this paper
• Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology.

  2017cites this paper
• Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non‐Down syndrome

  2017cites this paper
• Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children’s Oncology Group protocol AAML0531

  2017cites this paper
• ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1‐RUNX1T1 and associated with a better prognosis

  2017cites this paper
• Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra.

  2017cites this paper
• Etude des altérations génomiques acquises dans les leucémies aiguës myéloïdes impliquant le core binding factor

  2017cites this paper
• Prognostic Importance of C-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Systematic Review.

  2017cites this paper
• High level of miR-196b at newly diagnosed pediatric acute myeloid leukemia predicts a poor outcome

  2017cites this paper
• Andrographolide Suppresses MV4-11 Cell Proliferation through the Inhibition of FLT3 Signaling, Fatty Acid Synthesis and Cellular Iron Uptake

  2017cites this paper
• Microarray profiling and co-expression network analysis of the lncRNAs and mRNAs associated with acute leukemia in adults.

  2017cites this paper
• Quality Assurance Guided FISH-Analysis for Optimal Detection of AMLAssociated Chromosomal Aberrations

  2017cites this paper
• Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis.

  2017cites this paper
• Amyloid precursor protein has clinical and prognostic significance in AML1-ETO-positive acute myeloid leukemia

  2017cites this paper
• Clinical features and prognostic impact of PRDM16 expression in adult acute myeloid leukemia

  2017cites this paper
• Successful HLA-haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for refractory pediatric acute myeloid leuekmia after repeated Viridans streptococcal sepsis

  2016cites this paper
• Celastrol Induces Cell Apoptosis and Inhibits the Expression of the AML1-ETO/C-KIT Oncoprotein in t(8;21) Leukemia

  2016cites this paper
• Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

  2016influential citation
• Acute myeloid leukemia in children: Current status and future directions

  2016cites this paper
• Phospho-Inositol-3-Kinase Activity and Dysregulation in Pediatric Leukemia and Lymphoma

  2016cites this paper
• Whole‐exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia

  2016cites this paper
• Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial

  2015cites this paper
• Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group.

  2015influential citation
• Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.

  2015cites this paper
• 日本小児白血病リンパ腫研究グループ（JPLSG）のALL，AML臨床試験

  2015cites this paper
• Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors

  2015cites this paper
• Antiproliferating Activity of Esculetin on Acute Myeloid Leukemic Cell Line Potential Role in Therapy

  2015cites this paper
• Diagnosis and Treatment of Pediatric Acute Myeloid Leukemia

  2015cites this paper
• High Expression of c-kit mRNA Predicts Unfavorable Outcome in Adult Patients with t(8;21) Acute Myeloid Leukemia

  2015cites this paper
• Overexpressed miR-155 is associated with initial presentation and poor outcome in Chinese pediatric acute myeloid leukemia.

  2015cites this paper
• Markers for Diagnosis, Prognosis, and Therapy of Acute Myeloid Leukemia

  2014cites this paper
• Targeting PP2A activation as a novel therapeutic strategy for receptor tyrosine kinase driven leukaemia

  2014cites this paper
• Prognostic factor analysis in core-binding factor-positive acute myeloid leukemia.

  2014cites this paper
• Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocol

  2014cites this paper
• How I treat paediatric relapsed acute myeloid leukaemia

  2014cites this paper
• Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations.

  2014cites this paper
• Mutations of the GATA2 and CEBPA genes in paediatric acute myeloid leukaemia

  2014cites this paper
• Leukemia and Lymphoma

  2014cites this paper
• Identifying novel strategies to re-engage the apoptotic pathway for the treatment of cancer

  2014cites this paper
• Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations

  2014cites this paper
• AcuteMyeloid Leukemia with the t ( 8 ; 21 ) Translocation : Clinical Consequences and Biological Implications

  2014cites this paper
• Prevalence and prognostic significance of c-KIT mutations in core binding factor acute myeloid leukemia: a comprehensive large-scale study from a single Chinese center.

  2014cites this paper
• Frequent ASXL 2 mutations in acute myeloid leukemia patients with t ( 8 ; 21 ) / RUNX 1-RUNX 1 T 1 chromosomal translocations

  2014cites this paper
• C-KIT signaling in cancer treatment.

  2014cites this paper
• Mechanism of Transformation and Therapeutic Targets for Hematological Neoplasms Harboring Oncogenic KIT Mutation

  2014cites this paper
• Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children

  2013cites this paper
• TrkC promotes survival and growth of leukemia cells through Akt-mTOR-Dependent Up-Regulation of PLK-1 and Twist-1

  2013cites this paper
• The Etiology of Acute Leukemia

  2013cites this paper
• Cyclophosphamide as a first-line therapy in LGL leukemia

  2013cites this paper
• Update on Optimal Management of Acute Myeloid Leukemia

  2013influential citation
• Effects of c-KIT mutations on expression of the RUNX1/RUNX1T1 fusion transcript in t(8;21)-positive acute myeloid leukemia patients.

  2013cites this paper
• From Determinants of RUNX1/ETO Tetramerization to Small-Molecule Protein-Protein Interaction Inhibitors Targeting Acute Myeloid Leukemia

  2013cites this paper
• NUP98‐NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia

  2013cites this paper
• Evaluation of tyrosine-kinase receptor c-KIT (c-KIT) mutations, mRNA and protein expression in canine leukemia: might c-KIT represent a therapeutic target?

  2013cites this paper
• Core-binding factor acute myeloid leukemia: can we improve on HiDAC consolidation?

  2013cites this paper
• WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the Japanese Childhood AML Cooperative Study Group

  2013cites this paper
• The prognostic impact of c-KIT mutation in systemic mastocytosis associated with acute myeloid leukaemia patients.

  2013cites this paper
• Evaluation of tyrosine-kinase receptor c-kit mutations, mRNA and protein expression in canine lymphoma: might c-kit represent a therapeutic target?

  2013cites this paper
• NPM1, FLT3, and c-KIT Mutations in Pediatric Acute Myeloid Leukemia in Russian Population

  2013cites this paper
• Diagnosis and Treatment of Childhood Acute Myeloid Leukemia

  2013cites this paper
• Molecular-Based Classification of Acute Myeloid Leukemia and Its Role in Directing Rational Therapy

  2012cites this paper
• Systemic mastocytosis associated with t(8;21) acute myeloid leukemia in a child: Detection of the D816A mutation of KIT

  2012cites this paper
• Novel Therapies for Pediatric Cancers

  2012cites this paper
• Stem cell factor receptor/c-Kit: from basic science to clinical implications.

  2012cites this paper